Table 2.
Baseline characteristics of patients.
| Variables | Number (%) | Variables | Number (%) |
|---|---|---|---|
| Age, years | TNM stage | ||
| < 65 | 127 (42.9) | IA | 25 (8.4) |
| ≥ 65 | 169 (57.1) | IB | 87 (29.4) |
| Gender | IIA | 26 (8.8) | |
| Male | 177 (59.8) | IIB | 67 (22.6) |
| Female | 119 (40.2) | III | 37 (12.5) |
| BMI, Kg/m2 | IV | 22 (7.4) | |
| < 24 | 214 (72.3) | Unknown | 32 (10.8) |
| ≥ 24 | 82 (27.7) | CA50, ug/L | |
| Smoking | > 20 | 192 (64.9) | |
| Yes | 55 (18.6) | ≤ 20 | 57 (19.3) |
| No | 241 (81.4) | Unknown | 47 (15.9) |
| Drinking | CA19-9, U/ml | ||
| Yes | 31 (10.5) | > 37 | 240 (81.1) |
| No | 265 (89.5) | ≤ 37 | 56 (18.9) |
| Family history of cancer | CA125, U/ml | ||
| Yes | 8 (2.7) | > 35 | 54 (18.2) |
| No | 288 (97.3) | ≤ 35 | 215 (72.6) |
| Hypertension | Unknown | 27 (9.1) | |
| Yes | 114 (38.5) | CEA, ng/ml | |
| No | 182 (61.5) | > 5 | 86 (29.1) |
| Diabetes | ≤ 5 | 184 (62.2) | |
| Yes | 67 (22.6) | Unknown | 26 (8.8) |
| No | 229 (77.4) | Chemotherapy | |
| Tumor site | Yes | 149 (50.3) | |
| Head/Neck | 147 (49.7) | No | 147 (49.7) |
| Body/Tail | 118 (39.9) | ||
| Unknown | 31 (10.5) |